Photo from wikipedia
The aim of this study was to determine retrospectively the efficacy of combined therapy using erythropoietin (EPO) and erythrocytapheresis (EA) in patients with hereditary hemochromatosis (HH) who did not tolerate… Click to show full abstract
The aim of this study was to determine retrospectively the efficacy of combined therapy using erythropoietin (EPO) and erythrocytapheresis (EA) in patients with hereditary hemochromatosis (HH) who did not tolerate phlebotomy.
Keywords:
efficacy safety;
hemochromatosis;
efficacy;
erythrocytapheresis low;
safety erythrocytapheresis;
erythrocytapheresis
Journal Title: Journal of Clinical Apheresis
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Clinical Apheresis
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!